Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 527-531

  Landrum, Lisa M ^a   Hyde Jr , Johnny ^a   Mannel, Robert S ^a   McMeekin, D Scott ^a   Moore, Kathleen N ^a   Walker, Joan L ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cisplatin; Intraperitoneal catheter; Ototoxicity; Outpatient; Ovarian carcinoma

Indexed keywords

ANTIBIOTIC AGENT; APREPITANT; CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; ONDANSETRON; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; EYE TOXICITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEARING LOSS; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OTOTOXICITY; OUTCOME ASSESSMENT; OVARY CANCER; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIMARY PERITONEAL CANCER; PRIMARY PERITONEUM CANCER; PRIORITY JOURNAL; RASH; RECURRENT CANCER; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; THROMBOCYTOPENIA; UTERINE TUBE CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERIZATION; CISPLATIN; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PERITONEAL NEOPLASMS;

EID: 80051547682     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.022     Document Type: Article

References (22)

1. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 1 Jan. 5 2006 34 43 (Pubitemid 43048949)
2. D.S. Alberts, P.Y. Liu, E.V. Hannigan, R. O'Toole, S.D. Williams, and J.A. Young Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 26 Dec. 26 1996 1950 1955 (Pubitemid 26428219)
3. M. Markman, B.N. Bundy, D.S. Alberts, J.M. Fowler, D.L. Clark-Pearson, and L.F. Carson Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 4 Feb. 15 2001 1001 1007 (Pubitemid 32176274)
4. NCI Clinical Announcement: intraperitoneal chemotherapy for ovarian cancer January 5 2006 National Cancer Institute [cited 2006 Jan 27]
5. K. Rowan Intraperitoneal therapy for ovarian cancer: why has it not become standard? J Natl Cancer Inst 101 11 Jun. 3 2009 775 777
6. I. Vergote, F. Amant, K. Leunen, I. Cadron, G.T. Van, and P. Neven Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view Oncologist 13 4 Apr. 2008 410 414 (Pubitemid 351679920)
7. J.L. Walker, D.K. Armstrong, H.Q. Huang, J. Fowler, K. Webster, and R.A. Burger Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study Gynecol Oncol 100 1 Jan. 2006 27 32 (Pubitemid 41815045)
8. E. Connelly, M. Markman, A. Kennedy, K. Webster, B. Kulp, and G. Peterson Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity Gynecol Oncol 62 2 Aug. 1996 166 168 (Pubitemid 26274794)
9. E.A. Eisenhauer, W.W. ten Bokkel Huinink, K.D. Swenerton, L. Gianni, J. Myles, and M.E. van der Burg European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion J Clin Oncol 12 12 Dec. 1994 2654 2666 (Pubitemid 24379653)
10. L.G. Seamon, M.J. Carlson, D.L. Richardson, D.E. Cohn, J.M. Fowler, and L.J. Copeland Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer Int J Gynecol Cancer 19 7 Oct. 2009 1195 1198
11. E. Berry, K.S. Matthews, D.K. Singh, B.M. Buttin, J.R. Lurain, and R.D. Alvarez An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer Gynecol Oncol 113 1 Apr. 2009 63 67
12. S.N. Chin, V. Pinto, B. Rosen, A. Oza, J. Dodge, and J. Murphy Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma Gynecol Oncol 112 3 Mar. 2009 450 454
13. M. Markman, A. Kennedy, K. Webster, P. Elson, G. Peterson, and B. Kulp Clinical features of hypersensitivity reactions to carboplatin J Clin Oncol 17 4 Apr. 1999 1141
14. M. Pagani The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization Med Clin North Am 94 4 Jul. 2010 835 852 xiii
15. J.M. Rademaker-Lakhai, M. Crul, L. Zuur, P. Baas, J.H. Beijnen, and Y.J. Simis Relationship between cisplatin administration and the development of ototoxicity J Clin Oncol 24 6 Feb. 20 2006 918 924 (Pubitemid 46638845)
16. L. Nieves, J. Currie, J. Hoffman, and J.I. Sorosky Ototoxicity after intraperitoneal chemotherapy: a case report Int J Gynecol Cancer 17 5 Sep. 2007 1133 1135 (Pubitemid 47414841)
17. S. Makhija, M. Leitao, P. Sabbatini, N. Bellin, L. Almadrones, and L. Leon Complications associated with intraperitoneal chemotherapy catheters Gynecol Oncol 81 1 Apr. 2001 77 81 (Pubitemid 32368082)
18. S. Makhija, P. Sabbatini, and R.R. Barakat Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma Curr Opin Obstet Gynecol 11 1 Feb. 1999 23 27 (Pubitemid 29081083)
19. J.L. Lesnock, S.D. Richard, K.K. Zorn, T.C. Krivak, S. Beriwal, and P. Sukumvanich Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications Gynecol Oncol 116 3 Mar. 2010 345 350
20. L.M. Landrum, M.A. Gold, K.N. Moore, T.K. Myers, D.S. McMeekin, and J.L. Walker Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates Gynecol Oncol 108 2 2008 342 347 (Pubitemid 351181442)
21. S.A. Davidson, S.C. Rubin, M. Markman, W.B. Jones, T.B. Hakes, and B. Reichman Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system Gynecol Oncol 41 2 May 1991 101 106
22. J.L. Walker Intraperitoneal chemotherapy for ovarian cancer: 2009 goals Gynecol Oncol 112 3 Mar. 2009 439 440